Please login to the form below

statins

This page shows the latest statins news and features for those working in and with pharma, biotech and healthcare.

Novartis announces delay in UK cholesterol drug study

The trial is utilising NHS data to identify patients across the country who are at risk of heart disease who have not improved with conventional treatment regimens, including statins.

Latest news

CHMP recommends EU approval for Amarin’s cardiovascular risk reduction drug

The drug is recommended for use in adult patients who are already receiving statin treatment. ... The committee has recommended use of the drug in adult patients already receiving statin treatment, and who have elevated triglycerides.
AZ divests European rights for cholesterol med Crestor to Grünenthal

Crestor is a statin medication approved for the treatment of dyslipidaemia and hypercholesterolaemia, conditions that are characterised by the presence of high cholesterol levels in the blood.
Novartis scores CHMP backing for cholesterol drug Leqvio

The positive opinion is based on results from Novartis’ ORION clinical research programme, including phase 3 trials which involved over 3, 600 patients on a maximum statin dose. ... levels that have not been brought down by a maximum statin dose.
Amarin shares tumble following Vascepa patent loss

It became the first US Food and Drug Administration (FDA)-approved drug to reduce cardiovascular risk in patients with elevated triglyceride levels as an add-on to maximally tolerated statin therapy.
Esperion gets FDA thumbs up for cholesterol drug Nexletol

The US regulator has cleared Nexletol (bempedoic acid) as an add-on to diet and maximum-dose statin therapy for patients with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH), ... C-reactive protein”

More from news
Approximately 11 fully matching, plus 220 partially matching documents found.

Latest Intelligence

Sourcing R&D innovation: why pharma companies need to evolve their business models

Examples of this approach include developing statins for the treatment of dyslipidemia, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) for hypertension, and glucagon-like peptide 1
Treatment and prevention of cardiovascular disease

type 2 diabetes treatments, LDL cholesterol management with statins, blood pressure- lowering medications, antiplatelet agents and other treatments. ... These findings represented a potentially notable advance in cardiovascular disease prevention, after
Cortellis Drugs to Watch in 2020 report

It will face competition mainly from generic statins and PCSK9 inhibitor monoclonal antibodies.
A roadmap to the successful treatment of Alzheimer’s disease

This would create a similar situation to cardiovascular disease where we use cholesterol as a biomarker and give statins in a preventative mode.
Holding on to hope for Alzheimer’s advances

In terms of BACE, Prof Roberts said: “Although the drug companies would love to have a drug that you could take like statins against hypercholesterolaemia, to give long-term protection against

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

World Heart Day 2020: It's time to make our clinical trials more inclusive

This is a trend seen across various types of cardiovascular disease treatments, including statins, beta-blockers and ACE inhibitors.
Fake News is Bad for your Health

Millions of people take statins to reduce their risk of dying prematurely, but how would they feel if they were told that 67 people need to be treated to reduce one
Digital Marketing is no Substitute for Sound Strategic Marketing

To build equivalent marketing capabilities, pharmaceutical companies invested in training, processes and teams to create highly effective marketing machines, as illustrated by the ‘statin’ wars of the late 90’s/early
How do you define a biotech company?

benefit (eg: statins, PD-1s or TNFs).
The changing face of medical communications over the past 15 years

We used to work on products such as calcium-channel blockers, statins and ACE inhibitors.

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Omnichannel Strategy Consultant: Competitive Salary

Medical Writer, Women’s health, Medical Communications agency, h...: Highly competitive salary

Senior Account Manager: Competitive salary offered

PMHub

Add my company

certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

Committing time to making meaningful connections - top 5 tips: Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:: Senior Analytics Specialist joins Research Partnership...
Digital technologies: Pharma’s answer to achieving net zero emissions?: ...

Email:
Password:

Please login to the form below

statins

COVID-19 Updates and Daily News

Featured jobs

Quick links